Elsevier

Paediatric Respiratory Reviews

Volume 36, November 2020, Pages 52-56
Paediatric Respiratory Reviews

Mini-Symposium: Tuberculosis
Advances in the diagnosis of pulmonary tuberculosis in children

https://doi.org/10.1016/j.prrv.2020.05.003Get rights and content

Abstract

Major challenges still exist in the accurate diagnosis of tuberculosis in children. Algorithms based on clinical and radiological features remain in widespread use despite poor performance. Newer molecular diagnostics allow for rapid identification of TB and detection of drug-resistance in a subset of children, but lack sensitivity. Molecular testing of multiple specimens, including non-traditional specimen types, such as nasopharyngeal aspirates and stool and urine, may improve sensitivity, but the optimal combination of specimens requires further research. Novel tests under development or evaluation include a urine lipoarabinomannan test with improved sensitivity and a range of biomarkers measured from stimulated or unstimulated peripheral blood.

Section snippets

Educational aims

The reader will be able:

  • To highlight limitations in current diagnostic approaches for TB in children.

  • To review the role of nucleic acid amplification assays in the diagnosis of TB in children.

  • To identify specimen types most suitable for microbiological testing for TB in children.

  • To identify promising new tests in development or under evaluation.

Limitations of current diagnostic approaches

The substantial gap between tuberculosis (TB) notifications in children and the estimated true burden of illness [1] may, in part, be due to lack of awareness and screening, but likely also reflects the difficulty in establishing a confirmed diagnosis of pulmonary (PTB) in children. Most PTB diagnoses in children globally are made on clinical and radiological evidence, and microbiological confirmation remains unusual [1].

The reasons for the difficulty in confirming a diagnosis of PTB in

Diagnostic approaches differ by setting

Diagnostic algorithms and approaches vary substantially depending on the level of care, resource availability and prevalence of TB. For example, in a well-resourced, low-prevalence setting, children presenting with respiratory symptoms compatible with TB may be given an initial course of antibiotics; lack of response might indicate chest radiography and blood testing for inflammatory markers such as C-reactive protein or complete blood count. A history of recent travel to an endemic area or

Advances in the clinical diagnosis of TB in children

Clinical symptoms in children are non-specific, and clinical scoring systems perform with wide variability [15]. Symptom scores encompass clinical features, chest radiology and tuberculin skin testing. Clinical diagnosis may be especially challenging in HIV-infected, malnourished or young children. While TB was previously regarded as a chronic disease in children with the key clinical features being chronic cough or loss of weight in the preceding 2 to 3 months, it is increasingly recognised

Microscopy and culture for the diagnosis of TB in children

Smear microscopy is an insensitive test for TB in children. A recent meta-analysis of 15 paediatric studies which compared standard microbiological testing to nucleic acid amplification testing with Xpert MTB/RIF, found the pooled sensitivity of smear microscopy to be 22% (gastric aspirate) or 29% (induced/expectorated sputum) compared with mycobacterial culture [6]. Mycobacterial culture remains the most sensitive method for microbiological confirmation of TB in children, but since many

Nucleic acid amplification tests for the diagnosis of TB in children

The development and implementation of automated nucleic acid amplification tests (NAATs) for TB has been a significant advance [13]. Xpert MTB/RIF has led the field [19], however the BD MAX MDR-TB assay [20] from Becton Dickinson, has recently demonstrated similar accuracy to Xpert MTB/RIF in clinical testing. There are several important advantages to these tests: both are simultaneously able to detect the presence of M. tuberculosis DNA and identify resistance to rifampicin (the BD MAX assay

Alternative specimen types for microbiological testing for TB in children

Several studies have compared the microbiological yield (culture or Xpert MTB/RIF) from induced sputum samples with that from gastric aspirate or lavage. Results are conflicting, with some studies showing improved yield from induced sputum [8], [26], others from gastric aspirate/lavage [27], [28] and others no difference [29]. It is possible that this variation may reflect familiarity and expertise with collection of particular specimen types. More recently, nasopharyngeal sampling (aspirate or

Host biomarkers for the diagnosis of TB in children

Whilst microbiological diagnosis aims to detect the causative pathogen, diagnostic approaches using host biomarkers aim to identify a characteristic immune or inflammatory response to M. tuberculosis. Biomarkers may be measured from blood samples tested directly ex vivo, or from samples which are first stimulated with mycobacterial antigens, to elicit M. tuberculosis-specific responses. Commercially-available interferon-gamma release assays are based on the latter principle, and, while specific

Directions for future research

  • The assessment of diagnostic algorithms utilising clinical indicators and different diagnostic testing procedures.

  • Investigation of the best readily gathered samples [Saliva, sputum, blood, stool, urine] matched to available technology at point of care for diagnostic testing.

  • An evaluation of accurate, reliable and inexpensive testing kits for preferred diagnostic parameters at point of care sites.

Declarations of interest

The authors have received grant funding for paediatric TB diagnostic evaluation (Xpert MTB/RIF, Xpert MTB/RIF Ultra, AlereLAM, FujiLAM) from Regional Prospective Observational Research in Tuberculosis (RePORT TB) Consortium which is co-funded by the Medical Research Council of South Africa and the US Office of AIDS Research of the National Institutes of Health of the USA (DAA2-16-62066-1), the Medical Research Council of South Africa for the Tuberculosis Collaborating Centre for Child Health

References (52)

  • S.E. Dorman et al.

    Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

    Lancet Infect Dis

    (2018)
  • I. Sabi et al.

    Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study

    J Infect

    (2018)
  • R.A. Oberhelman et al.

    Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study

    Lancet Infect Dis

    (2010)
  • A. Gupta-Wright et al.

    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial

    Lancet

    (2018)
  • J.G. Peter et al.

    Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

    Lancet

    (2016)
  • T. Broger et al.

    Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study

    Lancet Infect Dis

    (2019)
  • D. Portevin et al.

    Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study

    Lancet Infect Dis

    (2014)
  • M. Hatherill et al.

    Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South Africa

    Bull World Health Organ

    (2010)
  • S.M. Graham et al.

    Clinical case definitions for classification of intrathoracic tuberculosis in children: an update

    Clin Infect Dis

    (2015)
  • Anderson ST, Kaforou M, Brent AJ, Wright VJ, Banwell CM, Chagaluka G, et al. Diagnosis of childhood TB in high TB/HIV...
  • H.J. Zar et al.

    Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens

    Clin Infect Dis

    (2012)
  • M.P. Nicol et al.

    Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reaction

    Sci Rep

    (2019)
  • E. MacLean et al.

    Diagnostic accuracy of stool Xpert MTB/RIF for detection of pulmonary tuberculosis in children: a systematic review and meta-analysis

    J Clin Microbiol

    (2019)
  • L. Olbrich et al.

    Rapaed TB: an innovative child TB diagnostic validation study

    Glob Health

    (2019)
  • E.C. Pearce et al.

    A systematic review of clinical diagnostic systems used in the diagnosis of tuberculosis in children

    AIDS Res Treat

    (2012)
  • Whitelaw AC, Mentoor, K., Zar, H.J., Nicol, M.P., (editor.) Standardmycobacterial decontamination protocols may be...
  • View full text